GAMMA Investing LLC Buys New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

GAMMA Investing LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 4,771 shares of the healthcare conglomerate’s stock, valued at approximately $2,441,000. UnitedHealth Group makes up approximately 0.7% of GAMMA Investing LLC’s investment portfolio, making the stock its 23rd largest holding.

Several other hedge funds have also recently bought and sold shares of UNH. Kraft Davis & Associates LLC lifted its position in UnitedHealth Group by 3.4% during the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after acquiring an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% in the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after purchasing an additional 19 shares during the period. Secure Asset Management LLC increased its stake in UnitedHealth Group by 0.8% during the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after buying an additional 19 shares during the period. Bensler LLC grew its stake in shares of UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after acquiring an additional 19 shares in the last quarter. Finally, Texas Capital Bancshares Inc TX lifted its stake in shares of UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after acquiring an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Barclays upped their target price on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Truist Financial reissued a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Morgan Stanley cut their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Finally, Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $4.86 during trading hours on Tuesday, hitting $486.37. 3,645,655 shares of the company’s stock traded hands, compared to its average volume of 4,543,351. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The company’s fifty day simple moving average is $488.10 and its two-hundred day simple moving average is $515.03. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a market cap of $448.40 billion, a price-to-earnings ratio of 29.72, a price-to-earnings-growth ratio of 1.38 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm posted $6.26 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s payout ratio is 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.